NCT00765102 2019-11-25Trial of Romidepsin and Bortezomib for Multiple MyelomaCelgenePhase 2 Terminated32 enrolled 14 charts
NCT00431990 2011-08-12A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed MyelomaPeter MacCallum Cancer Centre, AustraliaPhase 1/2 Unknown40 enrolled